EconPapers    
Economics at your fingertips  
 

Benefits and Risks of Self Medication

Carmel M. Hughes, James C. McElnay and Glenda F. Fleming
Additional contact information
Carmel M. Hughes: School of Pharmacy, The Queen’s University of Belfast
James C. McElnay: School of Pharmacy, The Queen’s University of Belfast
Glenda F. Fleming: School of Pharmacy, The Queen’s University of Belfast

Drug Safety, 2001, vol. 24, issue 14, No 2, 1027-1037

Abstract: Abstract Self medication is becoming an increasingly important area within healthcare. It moves patients towards greater independence in making decisions about management of minor illnesses, thereby promoting empowerment. Self medication also has advantages for healthcare systems as it facilitates better use of clinical skills, increases access to medication and may contribute to reducing prescribed drug costs associated with publicly funded health programmes. However, self medication is associated with risks such as misdiagnosis, use of excessive drug dosage, prolonged duration of use, drug interactions and polypharmacy. The latter may be particularly problematic in the elderly. Monitoring systems, a partnership between patients, physicians and pharmacists and the provision of education and information to all concerned on safe self medication, are proposed strategies for maximising benefit and minimising risk.

Keywords: European Union; Famotidine; Terfenadine; Community Pharmacist; Astemizole (search for similar items in EconPapers)
Date: 2001
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.2165/00002018-200124140-00002 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:24:y:2001:i:14:d:10.2165_00002018-200124140-00002

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.2165/00002018-200124140-00002

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-10-05
Handle: RePEc:spr:drugsa:v:24:y:2001:i:14:d:10.2165_00002018-200124140-00002